logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Cell Genesys, Inc.


USPTO Granted Patents = 78



Forward Citations = 3,095

Loading Chart...
Loading Chart...

94 inventors (with patents filed for the assignee):

goldMedal Deborah A Farson (16 out of 18 patents)

silverMedal Daniel R Henderson (16 out of 30 patents)

bronzeMedal Thomas L Dull (12 out of 15 patents)

4.  De-Chao Yu (11 out of 14 patents)

5.  Margo R Roberts (11 out of 13 patents)

6.  Mitchell H Finer (10 out of 12 patents)

7.  Daniel J Capon (9 out of 29 patents)

8.  Krisztina M Zsebo (9 out of 30 patents)

9.  Yuanhao Li (8 out of 9 patents)

10.  Luigi Naldini (7 out of 9 patents)

11.  Rochelle Witt (6 out of 8 patents)

12.  Eric R Schuur (6 out of 13 patents)

13.  James G McArthur (5 out of 11 patents)

14.  DeChao Yu (5 out of 6 patents)

15.  De Chao Yu (5 out of 6 patents)


Core Competencies:
Adenovirus Vectors
Oncolytic Vectors
Cancer Treatment
Gene Therapy
Transduction Enhancement
Lentiviral Vectors
Transcriptional Enhancers
Polypeptide Expression
Cancer-Associated Antigens
Recombinant Vectors
Cell-Specific Delivery
Peptide Cleavage Sites

78 patents:

1. 7575919 - Adenovirus vectors containing cell status-specific response elements and methods of use thereof (2009-08-18),
2. 7498024 - Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site (2009-03-03),
3. 7485291 - Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof (2009-02-03),
4. 7482156 - Hepatocellular carcinoma specific promoter and uses thereof (2009-01-27),
5. 7473418 - Pan cancer oncolytic vectors and methods of use thereof (2009-01-06),
6. 7459154 - Methods and reagents for the enhancement of virus transduction in the bladder epithelium (2008-12-02),
7. 7371570 - Cell-specific adenovirus vector comprising EBV-specific promoter (2008-05-13),
8. 7364727 - Metastatic colon cancer specific promoter and uses thereof (2008-04-29),
9. 7319033 - Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof (2008-01-15),
10. 7276233 - Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy (2007-10-02),
11. 7267815 - Methods and reagents for the enhancement of virus transduction in the bladder epithelium (2007-09-11),
12. 7252991 - Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells (2007-08-07),
13. 7250299 - Method and means for producing high titer, safe, recombinant lentivirus vectors (2007-07-31),
14. 7226606 - Cancer-associated antigens and methods of their identification and use (2007-06-05),
15. 7217421 - Cancer-associated antigens and methods of their identification and use (2007-05-15),
Cell Genesys, Inc. is a biotechnology company focused on the development and commercialization of novel cell therapies for the treatment of cancer. With a strong emphasis on research and innovation, Cell Genesys aims to revolutionize cancer treatment through advanced cellular engineering techniques. By harnessing the power of the immune system and genetic engineering, they strive to provide patients with safer and more effective therapies. Visit their website to learn more about their cutting-edge research and groundbreaking discoveries.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

78 Patents

#15 in South San Francisco, CA

#1,076 in California

#4,548 in US

#9,298 in the World

...
South San Francisco, CA, United States of America

Cell Genesys, Inc.

Forward Citations = 3,095

94 inventors:

goldMedal Deborah A Farson (16 out of 18 patents)

silverMedal Daniel R Henderson (16 out of 30 patents)

bronzeMedal Thomas L Dull (12 out of 15 patents)

4.  De-Chao Yu (11 out of 14 patents)

5.  Margo R Roberts (11 out of 13 patents)

Please report any incorrect information to support@idiyas.com
Loading…